Surrogate marker evaluation from an information theory perspective

被引:52
作者
Alonso, Ariel [1 ]
Molenberghs, Geert [1 ]
机构
[1] Hasselt Univ, Ctr Stat, B-3590 Diepenbeek, Belgium
关键词
hierarchical model; information theory; surrogate endpoints;
D O I
10.1111/j.1541-0420.2006.00634.x
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The last 20 years have seen lots of work in the area of surrogate marker validation, partly devoted to frame the evaluation in a multitrial framework, leading to definitions in terms of the quality of trial- and individual-level association between a potential surrogate and a true endpoint (Buyse et al., 2000, Biostatistics 1, 49-67). A drawback is that different settings have led to different measures at the individual level. Here, we use information theory to create a unified framework, leading to a definition of surrogacy with an intuitive interpretation, offering interpretational advantages, and applicable in a wide range of situations. Our method provides a better insight into the chances of finding a good surrogate endpoint in a given situation. We further show that some of the previous proposals follow as special cases of our method. We illustrate our methodology using data from a clinical study in psychiatry.
引用
收藏
页码:180 / 186
页数:7
相关论文
共 19 条
[11]   STATISTICAL VALIDATION OF INTERMEDIATE END-POINTS FOR CHRONIC DISEASES [J].
FREEDMAN, LS ;
GRAUBARD, BI ;
SCHATZKIN, A .
STATISTICS IN MEDICINE, 1992, 11 (02) :167-178
[12]   Confidence intervals and statistical power of the 'Validation' ratio for surrogate or intermediate endpoints [J].
Freedman, LS .
JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 2001, 96 (01) :143-153
[13]   ON INFORMATION AND SUFFICIENCY [J].
KULLBACK, S ;
LEIBLER, RA .
ANNALS OF MATHEMATICAL STATISTICS, 1951, 22 (01) :79-86
[14]   Statistical challenges in the evaluation of surrogate endpoints in randomized trials [J].
Molenberghs, G ;
Buyse, M ;
Geys, H ;
Renard, D ;
Burzykowski, T ;
Alonso, A .
CONTROLLED CLINICAL TRIALS, 2002, 23 (06) :607-625
[15]   Certain factors affecting telegraph speed [J].
Nyquist, H. .
BELL SYSTEM TECHNICAL JOURNAL, 1924, 3 (02) :324-346
[16]   SURROGATE ENDPOINTS IN CLINICAL-TRIALS - DEFINITION AND OPERATIONAL CRITERIA [J].
PRENTICE, RL .
STATISTICS IN MEDICINE, 1989, 8 (04) :431-440
[17]   Validation of surrogate endpoints in multiple randomized clinical trials with discrete outcomes [J].
Renard, D ;
Geys, H ;
Molenberghs, G ;
Burzykowski, T ;
Buyse, M .
BIOMETRICAL JOURNAL, 2002, 44 (08) :921-935
[18]   A MATHEMATICAL THEORY OF COMMUNICATION [J].
SHANNON, CE .
BELL SYSTEM TECHNICAL JOURNAL, 1948, 27 (04) :623-656
[19]   Statistical evaluation of biomarkers as surrogate endpoints: a literature review [J].
Weir, CJ ;
Walley, RJ .
STATISTICS IN MEDICINE, 2006, 25 (02) :183-203